×
Please click
here
if you are not redirected within a few seconds.
All
News
Maps
Images
Videos
Shopping
Books
Search tools
Recent
Recent
Past hour
Past 24 hours
Past week
Past month
Past year
RAPT Therapeutics stock plunges as FDA halts two clinical trials
MarketWatch
RAPT Therapeutics Inc. shares RAPT dropped more than 60% premarket on Tuesday after the company said regulators have hit pause on two...
2 months ago
FDA puts on hold two drug trials of Rapt Therapeutics in 'major setback'
Reuters
Rapt Therapeutics said on Tuesday the U.S. FDA had placed on hold two mid-stage trials of the company's drug to treat eczema and asthma,...
2 months ago
RAPT Therapeutics (RAPT) Catches Eye: Stock Jumps 6.1%
Yahoo Movies UK
RAPT Therapeutics, Inc. RAPT was a big mover last session, as the company saw its shares rise more than 6% on the day. The move came on solid volume too...
2 days ago
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of RAPT Therapeutics, Inc ...
PR Newswire
PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of RAPT Therapeutics, Inc. ("RAPT" or the "Company") (NASDAQ:...
1 month ago
FDA places clinical hold on RAPT Therapeutics' zelnecirnon trials
Clinical Trials Arena
The US Food and Drug Administration (FDA) has verbally communicated a clinical hold on two trials of RAPT Therapeutics' zelnecirnon.
2 months ago
RAPT Therapeutics Announces Clinical Hold on Studies Evaluating Zelnecirnon
GlobeNewswire
RAPT to host a conference call today at 8:30 am ET - SOUTH SAN FRANCISCO, Calif., Feb. 20, 2024 (GLOBE NEWSWIRE) -- RAPT Therapeutics, Inc.
2 months ago
RAPT Therapeutics Stock Is Down 63%. FDA Halts 2 Studies After Liver Failure.
Barron's
RAPT Therapeutics said the Food and Drug Administration has placed a hold on two trials of the drug zelnecirnon after a patient taking it...
2 months ago
Readout Newsletter: Bayer, Rapt Therapeutics, Sanofi shortage
STAT
Today's biotech news update includes the first cell therapy that can treat solid tumors, Sonata layoffs, and bacteriophage hurdles.
2 months ago
What Makes RAPT Therapeutics (RAPT) an Investment Choice?
Yahoo Finance
TimesSquare Capital Management, an equity investment management company, released its “U.S. Small Cap Growth Strategy” fourth-quarter...
1 month ago
RAPT ALERT: Bragar Eagel & Squire, P.C. is Investigating RAPT Therapeutics, Inc. on Behalf of RAPT Stockholders ...
KRQE
NEW YORK, March 11, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm,...
1 month ago